Susquehanna International Group, LLP Novo Cure LTD Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $123,319 - $184,386	-7,900 Reduced 5.68%	131,100 $2.05 Million
Q2 2024 Aug 15, 2024	SELL	$11.83 - $24.05 $1.04 Million - $2.12 Million	-88,100 Reduced 38.79%	139,000 $2.38 Million
Q1 2024 May 07, 2024	SELL	$12.42 - $17.29 $57,132 - $79,534	-4,600 Reduced 1.99%	227,100 $3.55 Million
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $607,698 - $861,588	-54,600 Reduced 19.07%	231,700 $3.46 Million
Q3 2023 Nov 14, 2023	SELL	$16.15 - $42.35 $507,109 - $1.33 Million	-31,400 Reduced 9.88%	286,300 $4.62 Million
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $6.14 Million - $12.6 Million	152,500 Added 92.31%	317,700 $13.2 Million
Q1 2023 May 16, 2023	BUY	$56.44 - $118.81 $722,432 - $1.52 Million	12,800 Added 8.4%	165,200 $9.94 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $2.62 Million - $3.5 Million	41,000 Added 36.8%	152,400 $11.2 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $2.98 Million - $3.93 Million	-43,900 Reduced 28.27%	111,400 $8.46 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $3.92 Million - $6.23 Million	-69,300 Reduced 30.85%	155,300 $10.8 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $2.11 Million - $2.96 Million	-35,000 Reduced 13.48%	224,600 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $4.84 Million - $7.86 Million	64,400 Added 32.99%	259,600 $19.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $3.53 Million - $5.91 Million	-30,400 Reduced 13.48%	195,200 $22.7 Million
Q2 2021 Aug 11, 2021	SELL	$130.4 - $225.58 $17.3 Million - $29.8 Million	-132,300 Reduced 36.97%	225,600 $50 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $3.85 Million - $5.9 Million	-31,000 Reduced 7.97%	357,900 $47.3 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $14.1 Million - $21.8 Million	125,400 Added 47.59%	388,900 $67.3 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $2.05 Million - $3.93 Million	35,300 Added 15.47%	263,500 $29.3 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $6.62 Million - $8.62 Million	-115,800 Reduced 33.66%	228,200 $13.5 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $11.9 Million - $20 Million	208,900 Added 154.63%	344,000 $23.2 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $5.04 Million - $6.92 Million	-73,800 Reduced 35.33%	135,100 $11.4 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $5.93 Million - $9.38 Million	95,900 Added 84.87%	208,900 $15.6 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $9.5 Million - $14.2 Million	-225,100 Reduced 66.58%	113,000 $7.15 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $2.93 Million - $5.15 Million	-91,700 Reduced 21.34%	338,100 $16.3 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $5.35 Million - $9.8 Million	-186,200 Reduced 30.23%	429,800 $14.4 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $2.36 Million - $3.87 Million	73,800 Added 13.61%	616,000 $32.3 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $4.13 Million - $6.65 Million	-207,900 Reduced 27.72%	542,200 $17 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $1.35 Million - $1.65 Million	-69,900 Reduced 8.52%	750,100 $16.4 Million
Q4 2017 Feb 14, 2018	SELL	$16.3 - $21.9 $606,360 - $814,680	-37,200 Reduced 4.34%	820,000 $16.6 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $15.5 Million - $18.6 Million	857,200	857,200 $17 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$195 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$191 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$128 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$69.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$48.8 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account